topicsindexquestionsbulletincontacts
conversationsreadsold poststeam

YD Bio Limited Successfully Finalizes Business Combination and Nasdaq Listing

August 29, 2025 - 01:58

YD Bio Limited Successfully Finalizes Business Combination and Nasdaq Listing

YD Bio Limited is set to embark on a new chapter as trading for its common stock and warrants is scheduled to begin on the Nasdaq Global Market on August 29, 2025. The company will be listed under the ticker symbols “YDES” for its common stock and “YDESW” for its warrants. This strategic move marks a significant milestone for YD Bio Limited, a biotechnology firm dedicated to pioneering advancements in DNA methylation-based cancer detection technologies and innovative solutions in ophthalmology.

The completion of the business combination positions YD Bio Limited for accelerated growth and market expansion, allowing it to leverage its cutting-edge technologies in a competitive landscape. With a commitment to enhancing healthcare through scientific innovation, YD Bio Limited aims to address critical challenges in cancer diagnostics and eye care. Stakeholders and investors are optimistic about the company's potential to drive advancements in these vital areas of medicine as it transitions into a publicly traded entity.


MORE NEWS

Daytona 500 weekend drawing big crowds to local businesses

February 15, 2026 - 06:48

Daytona 500 weekend drawing big crowds to local businesses

Local businesses in Daytona Beach are experiencing a significant boost in activity and revenue as crowds gather for the Daytona 500 weekend. The annual NASCAR season opener has transformed the...

“Smart Business” or “Bullying.” Taylor Swift Just Shut Down a “Swift Home” Trademark

February 14, 2026 - 18:46

“Smart Business” or “Bullying.” Taylor Swift Just Shut Down a “Swift Home” Trademark

Pop superstar Taylor Swift has successfully challenged a home goods company`s attempt to trademark the name `Swift Home,` leading to the immediate abandonment of the application. The move...

CCTA becoming an essential tool for interventional cardiologists

February 14, 2026 - 00:55

CCTA becoming an essential tool for interventional cardiologists

Coronary computed tomography angiography (CCTA) is fundamentally reshaping the landscape of interventional cardiology, transitioning from a diagnostic tool to an essential guide for complex heart...

Sachem Capital Provides Fourth Quarter and Full Year 2025 Business Update

February 13, 2026 - 00:10

Sachem Capital Provides Fourth Quarter and Full Year 2025 Business Update

Sachem Capital Corp., a leading real estate finance company, has released a preliminary business update for the fourth quarter and full year ending December 31, 2025. The announcement highlights...

read all news
topicsindexquestionspicksbulletin

Copyright © 2026 Indvex.com

Founded by: Caden Robinson

contactsconversationsreadsold poststeam
usagecookiesprivacy